In vitro and in vivo studies have demonstrated the action of GLP1-RAs through the suppression of endothelin-1 at the vascular level by decreasing the phosphorylation of nuclear factor kappa B (NF-κB) in the presence of elevated glucose concentrations, as occurs in patients with type 2 diabetes mellitus (DM2). The gene discussed is GLP1R; the disease is diabetes mellitus.